Go to content
UR Home

Hypertonicity counteracts MCL 1 and renders BCL XL a synthetic lethal target in head and neck cancer

URN to cite this document:
DOI to cite this document:
Ehrenschwender, Martin ; Heimer, Sina ; Knoll, Gertrud ; Neubert, Patrick ; Hammer, Karin P. ; Wagner, Stefan ; Bauer, Richard J. ; Jantsch, Jonathan
License: Creative Commons Attribution Non-commercial 4.0
PDF - Published Version
Date of publication of this fulltext: 26 Jan 2021 16:42


Head and neck squamous cell carcinoma (HNSCC) is an aggressive and difficult‐to‐treat cancer entity. Current therapies ultimately aim to activate the mitochondria‐controlled (intrinsic) apoptosis pathway, but complex alterations in intracellular signaling cascades and the extracellular microenvironment hamper treatment response. On the one hand, proteins of the BCL‐2 family set the threshold for ...


Owner only: item control page
  1. Homepage UR

University Library

Publication Server


Publishing: oa@ur.de

Dissertations: dissertationen@ur.de

Research data: daten@ur.de

Contact persons